| CAS No. | CATO-C4X-168417 |
| Molecular Formula | C10H22 |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
The occurrence of Lovastatin Impurity 17 is closely related to an organic framework in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
CATO supplies Lovastatin Impurity 17 (CAS CATO-C4X-168417), a pharmacopoeial impurity reference standard (molecular formula C10H22C5H12C3H7NC2H6, MW 301.60 g/mol) used for the identification and quantification of trace impurities in APIs.
Lovastatin Impurity 17 (C10H22C5H12C3H7NC2H6) contains an organic framework. Its high carbon-to-hydrogen ratio confers good lipid solubility; these physicochemical properties determine the optimal preparation and storage of its standard solutions. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Lovastatin Impurity 17 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Molecular Formula | C10H22 2*C5H12 C3H7N C2H6 |
| Molecular Weight | 301.60 g/mol |
| Purity | 95% |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | -2.0 |
| Nitrogen Atoms | 1 |